Literature DB >> 11420045

Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death.

F Andrade1, H G Bull, N A Thornberry, G W Ketner, L A Casciola-Rosen, A Rosen.   

Abstract

Cytotoxic lymphocytes kill virus-infected target cells and play a critical role in host recovery from viral infections. Granzyme B (GrB) is a cytotoxic lymphocyte granule protease that plays a critical role in mediating cytotoxicity. In these studies, we demonstrate that the adenovirus assembly protein L4--100K (100K) is a GrB substrate that prevents cytotoxic lymphocyte granule-induced apoptosis in infected target cells by potently inhibiting GrB. This inhibition is absolutely dependent on Asp-48 in 100K, found within a classic GrB consensus motif. 100K is the first viral protein described that exclusively targets the GrB pathway. It represents a novel class of viral protease inhibitor, in which an essential, multifunctional viral protein, which is vulnerable to specific proteolysis by GrB, expresses inhibitory function against that protease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420045     DOI: 10.1016/s1074-7613(01)00149-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  23 in total

1.  A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys.

Authors:  Kasey A Karen; Cailin Deal; Robert J Adams; Carolyn Nielsen; Cameron Ward; Diego A Espinosa; Jane Xie; Fidel Zavala; Gary Ketner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency.

Authors:  Joy Loh; Dori A Thomas; Paula A Revell; Timothy J Ley; Herbert W Virgin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 3.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 4.  Viral subversion of apoptotic enzymes: escape from death row.

Authors:  Sonja M Best
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

5.  Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor.

Authors:  Gabriel Gonzalez; Camden R Bair; Daryl M Lamson; Hidemi Watanabe; Laura Panto; Michael J Carr; Adriana E Kajon
Journal:  Virology       Date:  2019-09-08       Impact factor: 3.616

6.  Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.

Authors:  Chelsea Gerada; Megan Steain; Tessa Mollie Campbell; Brian McSharry; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

7.  Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response.

Authors:  Danielle B Ulanet; Michael Torbenson; Chi V Dang; Livia Casciola-Rosen; Antony Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

8.  Granzyme A- and B-cluster deficiency delays acute lung injury in pneumovirus-infected mice.

Authors:  Reinout A Bem; Job B M van Woensel; Rene Lutter; Joseph B Domachowske; Jan Paul Medema; Helene F Rosenberg; Albert P Bos
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

9.  Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine.

Authors:  Michael G Berg; Robert J Adams; Ratish Gambhira; Mark C Siracusa; Alan L Scott; Richard B S Roden; Gary Ketner
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

10.  Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting.

Authors:  Qiaoran Xi; Rafael Cuesta; Robert J Schneider
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.